PLG and Sepsis: Some studies have shown that COVID-19 patients have increased plasma thrombin levels and plasmin potential—in particular, high levels of plasmin-antiplasmin complex levels—compared with healthy donors and sepsis patients (34); nonetheless, in vitro analysis shows a hypofibrinolytic profile (31, 33) with an impaired response to r-tPA (32).